Loading data for ANGO — first visit, this takes a few seconds.

AngioDynamics, Inc.

NasdaqGS: ANGO · Real-Time Price · USD
15.27
+0.03 (0.20%)
At close: Sep 11, 2026, 8:00 PM
15.41
+0.92%
After-hours: 7:30 PM

The price, the headline numbers and the latest news, in one place.

AngioDynamics, Inc. (ANGO) Stock Price, Analysis & Data

No data available

Bid10.99
Market Cap631M
Revenue (ttm)320M
Net Income (ttm)-36.7M
0.33
-0.88
n/a
-339.33
P/B (ttm)3.73
P/S (ttm)1.97
Earnings DateJul 13, 2021
Ask15.29
Volume341,959
Avg. Volume (20D)454,904
Open15.44
Previous Close15.24
Day's Range15.06 - 15.47
52-Week Range9.39 - 16.29
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About ANGO

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus manageme...

Sector Healthcare
IPO Date Jun 1, 2004
Employees 632
Stock Exchange NasdaqGS
Ticker Symbol ANGO
Full Company Profile

Financial Performance

In 2026, AngioDynamics's revenue was 320.17M, an increase of 9.46% compared to the previous year's 292.5M. Earnings were -36.74M, an increase of 8.09%.

Financial Statements

Earnings Surprise

AngioDynamics has released their quarterly earnings on Jul 14, 2026:
  • Revenue of $86.61M misses estimates by $0, with 8.05% YoY growth.
  • EPS of -0.07 exceeds estimates by 0.02, with -333.33% YoY decline.
AngioDynamics, Inc. is scheduled to release its earnings on Jul 13, 2021, before market opens.
Analysts project revenue of ... Upgrade